Leonardo De Luca1, Federico Piscione2, Furio Colivicchi3, Donata Lucci4, Franco Mascia5, Barbara Marinoni6, Plinio Cirillo7, Daniele Grosseto8, Ciro Mauro9, Paolo Calabrò10, Federico Nardi11, Roberta Rossini12, Giovanna Geraci13, Domenico Gabrielli14, Andrea Di Lenarda15, Michele Massimo Gulizia16. 1. Division of Cardiology, S. Giovanni Evangelista Hospital, Tivoli, Roma, Italy. Electronic address: leo.deluca@libero.it. 2. Division of Preventive Cardiology, SS Giovanni di Dio e Ruggi d'Aragona Hospital, University of Salerno, Italy. 3. Division of Cardiology, S. Filippo Neri Hospital, Roma, Italy. 4. ANMCO Research Center, Firenze, Italy. 5. Division of Cardiology, S. Anna and Sebastiano Hospital, Caserta, Italy. 6. Fondazione IRCCS Pol. S. Matteo, Pavia, Italy. 7. Cardiology Unit, Federico II University of Naples, Italy. 8. Department of Cardiovascular Diseases, AUSL Rimini, Italy. 9. Division of Cardiology, AORN Cardarelli, Napoli, Italy. 10. Division of Cardiology, AORN Ospedale dei Colli- Monaldi, Napoli, Italy. 11. Division of Cardiology, Santo Spirito Hospital, Casale Monferrato, AL, Italy. 12. Division of Cardiology, S. Croce e Carle Hospital, Cuneo, Italy. 13. Division of Cardiology, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy. 14. Division of Cardiology, Augusto Murri Hospital, Fermo, Italy. 15. Division of Cardiology, Azienda Sanitaria Universitaria Integrata di Trieste, Italy. 16. Division of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy.
Abstract
AIMS: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). METHODS: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. RESULTS: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15-28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79-2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19-5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. CONCLUSIONS: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.
AIMS: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). METHODS: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. RESULTS: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15-28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79-2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19-5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. CONCLUSIONS: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.